Determination of Atypical Nonlinear Plasma–Protein-Binding Behavior of Tigecycline Using an In Vitro Microdialysis Technique
- 1 March 2014
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 103 (3) , 1013-1019
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteersInternational Journal of Antimicrobial Agents, 2012
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority TrialsClinical Infectious Diseases, 2012
- Tigecycline: A Review of Properties, Applications, and Analytical MethodsTherapeutic Drug Monitoring, 2010
- Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgeryInternational Journal of Antimicrobial Agents, 2009
- Tigecycline: a new glycylcycline antimicrobialInternational Journal Of Clinical Practice, 2006
- Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2005
- In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesJournal of Antimicrobial Chemotherapy, 2003
- In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2000
- In-vitro susceptibility of anaerobic bacteria to gar-936, a new glycylcyclineClinical Microbiology and Infection, 2000
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000